TITLE

Early detection: The ease of detection

AUTHOR(S)
Greenwood, Emma
PUB. DATE
April 2003
SOURCE
Nature Reviews Cancer;Apr2003, Vol. 3 Issue 4, p235
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cites a study conducted by researchers Andrew Feinberg et al., published in 14 March 2003 issue of the journal 'Science,' on the efficacy of a technique called loss of imprinting (LOI) to predict the risk of developing colorectal cancer. Potential of genetic and epigenetic changes to initiate tumorigenesis; Effect of loss of imprinting on silenced alleles of genes that could lead to tumor formation; Benefits of LOI blood test for detection of colorectal cancer.
ACCESSION #
9435544

 

Related Articles

  • Screening for colorectal cancer1 1Liebermann DA, Weiss DG One-Time Screening for Colorectal Cancer With Combined Fecal Occult-Blood Testing (FOBT) and Examination of the Distal Colon NEJM 2001;345:555–60 Alazmi, Waleed M.; Barkin, Jamie S. // American Journal of Gastroenterology;Jul2002, Vol. 97 Issue 7, p1837 

    This report is on the yield of one-time screening for colorectal cancer with combined fecal occult blood tests (FOBTs) and examination of the distal colon. The study population included 2885 subjects without symptoms who underwent one-time FOBT and colonoscopy. The information obtained from the...

  • Costs of bowel Ca screening to soar.  // Pulse;3/15/2007, Vol. 67 Issue 10, p15 

    The article focuses on a new British analysis which warns that bowel cancer screening will send demand for endoscopy by 69%. Figures based on the British colorectal cancer screening pilot suggest the resulting costs are expected to outstrip the allocated cash. About 1.9% of patients are likely...

  • Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain. Garcia, M.; Domènech, X.; Vidal, C.; Torné, E.; Milà, N.; Binefa, G.; Benito, L.; Moreno, V. // Gastroenterology Research & Practice;2/24/2015, Vol. 2015, p1 

    Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a...

  • COLORECTAL CANCER. Round, Alison; Weller, David // Pulse;3/22/2007, Vol. 67 Issue 11, p46 

    The article discusses the benefits of medical screening for early identification of colorectal cancer. The incidence of bowel cancer is highest in Great Britain but survival rates have improved due to early diagnosis and screening. Fecal occult blood testing is considered at the only method of...

  • CT colonography in detection of colorectal carcinoma. Sofic, Amela; Beslic, Serif; Kocijancic, Igor; Sehovic, Nedzad // Radiology & Oncology;2010, Vol. 44 Issue 1, p19 

    Background. Diagnostic methods used in screening and detecting colorectal carcinoma are digitorectal examination, faecal occult blood testing, sigmoidoscopy, DNA stool analysis, barium enema, colonoscopy, and as of recently CT colonography. The aim of this study was to establish diagnostic...

  • Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. van Rossum, L. G. M.; van Rijn, A. F.; Laheij, R. J. F.; van Oijen, M. G. H.; Fockens, P.; Jansen, J. B. M. J.; Verbeek, A. L. M.; Dekker, E. // British Journal of Cancer;10/20/2009, Vol. 101 Issue 8, p1274 

    Background:The cutoff of semi-quantitative immunochemical faecal occult blood tests (iFOBTs) influences colonoscopy referrals and detection rates. We studied the performance of an iFOBT (OC-Sensor) in colorectal cancer (CRC) screening at different cutoffs.Methods:Dutch screening participants,...

  • Advances in Fecal Occult Blood Tests: The FIT Revolution. Young, Graeme; Symonds, Erin; Allison, James; Cole, Stephen; Fraser, Callum; Halloran, Stephen; Kuipers, Ernst; Seaman, Helen // Digestive Diseases & Sciences;Mar2015, Vol. 60 Issue 3, p609 

    There is a wide choice of fecal occult blood tests (FOBTs) for colorectal cancer screening. Goal: To highlight the issues applicable when choosing a FOBT, in particular which FOBT is best suited to the range of screening scenarios. Four scenarios characterize the constraints and expectations of...

  • A New Generation of Molecular Stool Testing. Mak, Tony; Hill, James // Current Medical Literature: Colorectal Cancer;2011, Vol. 4 Issue 4, p105 

    The article discusses the pathophysiology of colorectal neoplasia and describes the existing modalities in molecular stool testing for colorectal cancer (CRC) screening. It says that molecular stool testing can become a significant alternative method to fecal occult blood testing (FBOT). It...

  • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Church, Timothy Robert; Wandell, Michael; Lofton-Day, Catherine; Mongin, Steven J.; Burger, Matthias; Payne, Shannon R.; Castaños-Vélez, Esmeralda; Blumenstein, Brent A.; Rösch, Thomas; Osborn, Neal; Snover, Dale; Day, Robert W.; Ransohoff, David F. // Gut;Feb2014, Vol. 63 Issue 2, p317 

    Background As screening methods for colorectal cancer (CRC) are limited by uptake and adherence, further options are sought. A blood test might increase both, but none has yet been tested in a screening setting. Objective We prospectively assessed the accuracy of circulating methylated SEPT9 DNA...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics